Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:APHA
Previous Symbol
CUSIPN/A
WebN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$29.05 million
Price / Sales49.26
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares249,760,000
Market Cap$1.40 billion
OptionableNot Optionable
Aphria (NYSE:APHA) Frequently Asked Questions
What is Aphria's stock symbol?
Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."
How were Aphria's earnings last quarter?
Aphria Inc (NYSE:APHA) posted its quarterly earnings results on Friday, October, 12th. The company reported $0.07 EPS for the quarter. The firm earned $10.15 million during the quarter. View Aphria's Earnings History.
When is Aphria's next earnings date?
What price target have analysts set for APHA?
2 analysts have issued twelve-month price targets for Aphria's stock. Their predictions range from $7.00 to $7.00. On average, they expect Aphria's stock price to reach $7.00 in the next year. This suggests a possible upside of 22.2% from the stock's current price. View Analyst Price Targets for Aphria.
What is the consensus analysts' recommendation for Aphria?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.
Has Aphria been receiving favorable news coverage?
Headlines about APHA stock have trended negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Aphria earned a coverage optimism score of -2.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next several days.
Are investors shorting Aphria?
Aphria saw a increase in short interest in the month of November. As of November 30th, there was short interest totalling 16,564,790 shares, an increase of 41.7% from the November 15th total of 11,688,291 shares. Based on an average daily trading volume, of 2,057,219 shares, the short-interest ratio is currently 8.1 days. View Aphria's Current Options Chain.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include GN STORE NORD A/ADR (GNNDY), athenahealth (ATHN), GALAPAGOS NV/S (GLPG), Haemonetics (HAE), Amarin (AMRN), Alkermes (ALKS), Premier (PINC), Catalent (CTLT), Sartorius (SARTF), HYPERA S A/S (HYPMY), Amneal Pharmaceuticals (AMRX), SAGE Therapeutics (SAGE), DiaSorin (DSRLF), Insulet (PODD) and United Therapeutics (UTHR).
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Mr. Victor Neufeld, Chairman & CEO (Age 64)
- Mr. Cole Cacciavillani, Co-Founder, VP of Growing Operations & Director (Age 63)
- Mr. John Cervini, Co-Founder, VP of Infrastructure & Technology and Director (Age 48)
- Mr. Carl A. Merton, Chief Financial Officer
- Ms. Megan McCrae, Director of Marketing
How do I buy shares of Aphria?
Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $5.73.
How big of a company is Aphria?
Aphria has a market capitalization of $1.40 billion and generates $29.05 million in revenue each year.
MarketBeat Community Rating for Aphria (NYSE APHA)
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
